推荐产品
一般說明
Short chain fatty acids (SCFAs) are saturated fatty acids with less than 6 carbons. SCFAs are produced in the gut by microbial fermentation of dietary fibers. The most important and researched SCFAs are Acetate (Ac), propionate (Pr) and butyrate (Bu). SCFAs are predominantly found in the colon and cross the intestinal epithelium to the blood stream. SCFAs were found to be beneficial and effective in prevention of obesity, Non-alcoholic fatty liver disease and insulin resistance.
The concentration of SCFAs in Stool is varied from subject to subject in dependence to the experiment parameters. The Average concentration for Acetate, Propionate and Butyrate 30, 10, 10 μM respectively.
13C-SCFAs can serve in various applications:
The concentration of SCFAs in Stool is varied from subject to subject in dependence to the experiment parameters. The Average concentration for Acetate, Propionate and Butyrate 30, 10, 10 μM respectively.
13C-SCFAs can serve in various applications:
- spiking the mixture to track sample preparation errors.
- QC sample, to exclude run to run variations and to normalize the runs.
- Calibration curve to quantify SCFAs in Stool samples.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類(WGK)
nwg
閃點(°F)
Not applicable
閃點(°C)
Not applicable
Cell, 165(6), 1332-1345 (2016-06-04)
A compelling set of links between the composition of the gut microbiota, the host diet, and host physiology has emerged. Do these links reflect cause-and-effect relationships, and what might be their mechanistic basis? A growing body of work implicates microbially
Gut, 28(10), 1221-1227 (1987-10-01)
Evidence for the occurrence of microbial breakdown of carbohydrate in the human colon has been sought by measuring short chain fatty acid (SCFA) concentrations in the contents of all regions of the large intestine and in portal, hepatic and peripheral
Nature reviews. Endocrinology, 15(5), 261-273 (2019-01-24)
Evidence is accumulating that the gut microbiome is involved in the aetiology of obesity and obesity-related complications such as nonalcoholic fatty liver disease (NAFLD), insulin resistance and type 2 diabetes mellitus (T2DM). The gut microbiota is able to ferment indigestible
British journal of pharmacology, 172(11), 2782-2798 (2015-01-07)
Sodium butyrate (NaB), an epigenetic modifier, is effective in promoting insulin sensitivity. The specific genomic loci and mechanisms underlying epigenetically induced obesity and insulin resistance and the targets of NaB are not fully understood. The anti-diabetic and anti-obesity effects of
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门